Market Research

Psychedelic Invest is your source for the latest business and investing news about the burgeoning psychedelics industry.

Genetics and Psychedelics: Do You Inherit Your Trip?

Sep 27 • 5 min read

Genetics can influence every area of our biology, including how we respond to psychedelics. Understanding the roles that our genes play is essential when developing new therapies and mental health treatment options. Let’s dive deeper into this and discuss how your genetics could impact someone’s reaction to psychedelics. Brain Chemistry We all have a brain…

Colorado Votes For Psilocybin Access

Sep 22 • 6 min read

As the public perception of psychedelics begins to shift, so too are the regulations that govern them. Back in 2020, Oregon became the first state in the US to legalize the use of psychedelic mushrooms with Measure 109. Colorado may be the next state to follow in its footsteps with the legalization of Psilocybin and…

San Francisco’s Decriminalization: What Does It Mean?

Sep 20 • 6 min read

San Francisco, unsurprisingly, has become the next American city to decriminalize psychedelics. They are following the lead of over a dozen other cities nationwide that have voted over the past few years to decriminalize some psychedelic compounds. Having been the center of the psychedelic movement back in the 60s, it comes as no surprise that…

Psychedelic Stock Market Update August 2022: ETF Edition

Sep 15 • 10 min read

In 2021, one of the leading stories for psychedelic stock investors was the introduction of ETFs focused on the burgeoning sector. Here at Psychedelic Invest, we published multiple news alerts (here and here for example) and deep dives around the introduction of said ETFs. But with the announcement from ETF provider Defiance last month that…

Psychedelic Analogues Solve The Problems Of Limiting Psychedelic Treatment Model

Sep 15 • 17 min read

Traditional psychedelics have shown great potential for treating issues like depression, anxiety, PTSD, and addiction. Psilocybin and MDMA will likely be available for patients in the next couple of years with other psychedelic compounds like LSD and DMT following suit. Even if these compounds can significantly help those who have access to them, there are…

Pages: 1234567891011121314151617181920212223242526272829303132333435363738394041424344454647484950515253